GLP-1 Agonists In Obesity
US$ 29.30
new glp-1 drugs in development Novo cuts prices 70%, but semaglutide revenue could grow 2026 Issue 42: GLP-1 RA Drug
Description
Crump, R
Global GLP-1 Receptor Agonist Market Segmentation 1) By Drug Class: Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs 2) By Route Of Administration: Parenteral, Oral 3) By End Users: Hospitals, Surgical Clinics, Other Users What Is The Driver Of The GLP-1 Receptor Agonist Market
Molecular medicine reports
Survodutide also achieved all secondary endpoints, including statistically significant improvement in liver fibrosis
For healthy adults : Experts are split
